Five-year survival in patients with unresectable hepatocellular carcinoma sets milestone

Published Date: 23 Jul 2025

A new exploratory analysis of the HIMALAYA phase III trial involving patients with unresectable hepatocellular carcinoma (uHCC, an advanced liver cancer that could not be treated with surgery or other localized treatments) ...

Read Full News

Latest News

Radiation therapy for patients with breast cancer

Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells and reduce the risk of the cancer recurring.

Discovery of breast cancer treatment resistance mechanism could lead to new hope for some

Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...

AI tool identifies women at high risk of interval breast cancer

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...

Study finds higher breast cancer rates in areas with more air pollution

Women living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...

'Sleep ALL night' program helps children with leukemia sleep better during treatment

Disrupted sleep is a common, often overlooked problem for pediatric patients being treated for acute lymphoblastic leukemia (ALL). To address this issue, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders ...

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we and our colleagues published ...

Todays Updates

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

FDA approves Blenrep for relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Todays Updates

Molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target

Researchers at The University of Texas MD Anderson Cancer Center, in collaboration with BostonGene, conducted the largest and most comprehensive molecular analysis of renal medullary carcinoma (RMC), a rare and aggressive ...

FDA approves Blenrep for relapsed or refractory multiple myeloma

The U.S. Food and Drug Administration approved Blenrep (belantamab mafodotin-blmf) in combination with bortezomib and dexamethasone for the treatment of adult patients with relapsed or refractory multiple myeloma.

Latest News

Radiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells and reduce the risk of the cancer recurring.

Mayo Clinic researchers have discovered a key reason why certain breast cancers might not respond to an important new class of therapeutics called antibody drug conjugates (ADCs). These treatments pair an antibody that targets ...

In a study of more than 100,000 screening mammograms, researchers demonstrated the potential of an AI tool to help identify women at higher risk of developing interval breast cancer, which is breast cancer that is diagnosed ...

Women living in parts of the United States with lower air quality, especially neighborhoods with heavy emissions from motor vehicles, are more likely to develop breast cancer, according to a multiyear analysis involving more ...

Disrupted sleep is a common, often overlooked problem for pediatric patients being treated for acute lymphoblastic leukemia (ALL). To address this issue, researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders ...

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new study that we and our colleagues published ...

News All Time

Obesity-related cancer rising among both younger and older adults worldwide, study finds

A surveillance study compared international cancer incidence trends of 13 cancer types in younger and older adults.

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

Within the last two decades, multiple stem cell transplants and immunotherapy have been added to intensive chemotherapy as the standard of care for high-risk neuroblastoma, drastically improving survival of this childhood ...

Research finds COVID-19 mRNA vaccine sparks immune response to fight cancer

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy drugs lived significantly longer than those who did not get the vaccine, researchers have found.

mRNA-based COVID vaccines generate improved responses to immunotherapy

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers ...

Oral drug combination extends progression-free survival in advanced ER-positive breast cancer

Patients with estrogen-receptor-positive HER-2-negative advanced breast cancer showed significantly improved progression-free survival when treated with an oral combination regimen that includes giredestrant, a novel, next-generation ...

Dense breasts: What it means and what women can do about screening

About half of women over 40 have dense breasts. The denser the breast tissue, the more difficult it is to spot cancer on a standard mammogram. Having dense breast tissue can make it harder to detect cancer and sometimes leads ...

Should the UK introduce targeted prostate cancer screening? The case for and against

Former UK prime minister Rishi Sunak has called for a targeted prostate cancer screening program for men most at high risk of the disease, reviving a national debate on how to save more lives and tackle health inequalities ...

Chemotherapy combination boosts overall survival in patients with EGFR-mutant non-small cell lung cancer

In recent research, treatment with osimertinib plus a platinum–pemetrexed chemotherapy combination resulted in statistically significant and clinically meaningful improvement in overall survival in patients with newly diagnosed ...

Leukemia cells evade treatment by reshaping their mitochondria, researchers discover

Researchers from Rutgers Health and other institutions have discovered why a powerful leukemia drug eventually fails in most patients—and found a potential way to overcome that resistance.

Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death

The ultimate cause of death from cancer may not be metastatic disease, as researchers have long surmised, but an infiltration of tumors into major blood vessels that cause blood clots and multiorgan failure, a one-of-a-kind ...

High-speed whole-body SPECT tracks tumor evolution to optimize prostate cancer treatment

A new fast and convenient approach to scintigraphy-based monitoring allows physicians to efficiently and reliably assess prostate cancer progression or regression during treatment. With this strong prognostic information, ...

After cancer: Study explores caring-healing modalities for survivors

As cancer survivorship rises, many people living with or beyond cancer face lasting physical and emotional challenges—particularly anxiety and depression, which affect about 30% of this population. Emotional distress is ...

Study identifies new approach to protect the brain during radiation therapy

While tremendous relief comes from successfully battling cancer, survivors can also experience cognitive impairments caused by the disease and its treatment. Up to 70% of survivors experience trouble with memory and concentration, ...

New imaging solution could help improve survival for patients with recurring prostate cancer

A multicenter study led by London Health Sciences Centre Research Institute (LHSCRI), Lawson Research Institute of St. Joseph's Health Care London (Lawson), and University Health Network (UHN) has found a novel imaging solution, ...

Prior authorizations draining time, energy from many cancer patients

Cancer patients aren't just battling a deadly disease—part of their time and energy can also be spent fighting the system intended to cure them, a new study says. The findings are published in the journal JCO Oncology Practice.

Breast awareness: What to look for in your self-exam

October is Breast Cancer Awareness Month, and cancer awareness starts with general breast awareness. Dr. Julie Nangia, medical director of breast oncology at the Dan L Duncan Comprehensive Cancer Center, recommends monthly ...

Recommended News For You

Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma

Limited Benefit from New Drugs; Significant Increase in Drug Prices; AI Boost for Mammo Results.

Papillary thyroid cancer: New markers offer hope for tailored treatment

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

Breast Cancer Incidence Increased Due to Particulate Air Pollution, According to NIH Study.

Loneliness and social isolation linked to heightened risk of death in those with cancer

Research suggests peer support may lower depression, stress among cancer patients in low-resource settings

Recommended Articles For You

Botulinum Toxins in Oncology: A New Frontier in Chronic Pain Management and Apoptosis Induction 

Exploring the Causes and Treatment of Granulocytopenia: A Comprehensive Guide 

Exploring the Potential of Bendamustine in Cancer Treatment 

Uncovering the Causes of Thrombocytosis: A Journey to Improved Health 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Anti-PD-L1 Plus Targeted Agent No Better Than Chemo for Resistant NSCLC

2.

For patients with prostate cancer, long-term follow-up helps identify treatment side effects.

3.

fresh E. Coli Outbreak: ECMO Redefining Death and Bringing Universal Blood One Step Nearer.

4.

NEJM: Fluorescent guide can aid in the detection of tumors that are still present after breast cancer surgery.

5.

Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation

1.

Chemotherapy Advances: Albumin I.V., Trastuzumab, Liposomal Doxorubicin & More

2.

Phosphate Vs. Phosphorus: What Is The Difference?

3.

Cancer in 2024: Global Trends, Challenges, and Innovations for Healthcare Professionals

4.

Exploring New Treatment Options for Hemophilia: A Journey into the Unknown

5.

Understanding the Role of CA 19-9 in Cancer Diagnosis and Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment

2.

Efficient Management of First line ALK-rearranged NSCLC - Part III

3.

An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Further Talks

4.

Should We Use DARA Up Front As First-Line Therapy in MM? - Part II

5.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part I

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot